speb/financial-data huggingface dataset:
Financial ratios for ABUS — quarterly report dated 2025-03-31
Total revenue: 1764000
Operating income: -13027000
Net income: -24526000
Capital expenditures: 0
Operating cash flow: -13391000
Depreciation & amortization: 330000
Net tangible assets: 79157000
Owner earnings: -24196000
Return on net tangible assets (%): -30.567100824942834
Buffett classification: The Gruesome
Stock price: 3.49
Shares outstanding: 197537710
Book value: 79157000
P/B ratio: 8.70935745291004
Market cap (USD): 689406607.9000001
Debt to equity: 0.015020781484897104
Current ratio: 6.011425042457928
Quick ratio: 6.011425042457928
Interest coverage ratio: -465.25
COGS to revenue (%): 0
R&D to revenue (%): 507.8798185941043
SG&A to revenue (%): 330.6122448979592
Free cash flow (dilution-adjusted): -16955000
Buyback yield (%): 0
Retained earnings: -1371098000
Receivables turnover: 1.4923857868020305
Capitalized R&D asset: 8959000
ROCI (R&D-adjusted, %): -6.621424593415809
FCF margin (%): -961.1678004535147
Rule of 40 score: -961.1678004535147
Financial ratios for ABUS — quarterly report dated 2025-06-30
Total revenue: 1953255.73
Operating income: 1913000
Net income: 2523000
Capital expenditures: 9000
Operating cash flow: -15749000
Depreciation & amortization: 11000
Net tangible assets: 82976000
Owner earnings: 2525000
Return on net tangible assets (%): 3.043048592364057
Capex to operating income (%): 0.4704652378463147
Buffett classification: The Great
Stock price: 3.09
P/E ratio: 60.482711444708684
Shares outstanding: 197537710
Book value: 82976000
P/B ratio: 7.356241851860778
Market cap (USD): 610391523.9
Debt to equity: 0.01312427689934439
Current ratio: 20.533452807646356
Quick ratio: 20.533452807646356
Interest coverage ratio: 68.32142857142857
COGS to revenue (%): 0
R&D to revenue (%): 281.478759568262
SG&A to revenue (%): 170.38219567900614
Free cash flow (dilution-adjusted): -16613000
Buyback yield (%): 0
Retained earnings: -1368575000
Receivables turnover: 1.9056153463414633
Capitalized R&D asset: 11500530
ROCI (R&D-adjusted, %): 2.361827401990769
FCF margin (%): -850.5286709180676
Revenue growth (%): 10.728782879818594
Rule of 40 score: -839.799888038249
Financial ratios for ABUS — quarterly report dated 2025-09-30
Total revenue: 529000
Operating income: -8293000
Net income: -7742000
Capital expenditures: 0
Operating cash flow: -5817000
Depreciation & amortization: 11000
Net tangible assets: 77399000
Owner earnings: -7731000
Return on net tangible assets (%): -9.988501143425625
Buffett classification: The Gruesome
Stock price: 4.54
Shares outstanding: 197537710
Book value: 77399000
P/B ratio: 11.586986955903823
Market cap (USD): 896821203.4
Debt to equity: 0.011912298608509155
Current ratio: 18.796682098765434
Quick ratio: 18.796682098765434
Interest coverage ratio: -360.5652173913044
COGS to revenue (%): 0
R&D to revenue (%): 1092.249527410208
SG&A to revenue (%): 575.4253308128544
Free cash flow (dilution-adjusted): -7080000
Buyback yield (%): 0
Retained earnings: -1376317000
Receivables turnover: 0.5845303867403315
Capitalized R&D asset: 12418130
ROCI (R&D-adjusted, %): -8.82374269051542
FCF margin (%): -1338.374291115312
Revenue growth (%): -72.91701276616759
Rule of 40 score: -1411.2913038814795
Financial ratios for ABUS — quarterly report dated 2025-12-31
Total revenue: 1051000
Operating income: -7644000
Net income: -3756000
Capital expenditures: 355000
Operating cash flow: -4680000
Depreciation & amortization: 11000
Net tangible assets: 76576000
Owner earnings: -4100000
Return on net tangible assets (%): -5.354157960718763
Buffett classification: The Gruesome
Stock price: 4.81
Shares outstanding: 197537710
Book value: 76576000
P/B ratio: 12.408017983441287
Market cap (USD): 950156385.0999999
Debt to equity: 0.009741955704137066
Current ratio: 15.726939726939728
Quick ratio: 15.726939726939728
Interest coverage ratio: -424.6666666666667
COGS to revenue (%): 0
R&D to revenue (%): 476.30827783063745
SG&A to revenue (%): 350.9990485252141
Free cash flow (dilution-adjusted): -5942000
Buyback yield (%): 0
Retained earnings: -1380073000
Receivables turnover: 0.7263303386316516
Capitalized R&D asset: 10691600
ROCI (R&D-adjusted, %): -8.121894204573985
FCF margin (%): -565.3663177925785
Revenue growth (%): 98.67674858223062
Rule of 40 score: -466.6895692103478
Financial ratios for ABUS — annual report dated 2025-12-31
Total revenue: 14083000
Operating income: -27051000
Net income: -33501000
Capital expenditures: 364000
Operating cash flow: -39637000
Depreciation & amortization: 363000
Net tangible assets: 76576000
Owner earnings: -33502000
Return on net tangible assets (%): -43.75
Buffett classification: The Gruesome
Stock price: 4.81
Shares outstanding: 197537710
Book value: 76576000
P/B ratio: 12.408017983441287
Market cap (USD): 950156385.0999999
Debt to equity: 0.009741955704137066
Current ratio: 15.726939726939728
Quick ratio: 15.726939726939728
Interest coverage ratio: -278.87628865979383
COGS to revenue (%): 0
R&D to revenue (%): 179.23027763970745
SG&A to revenue (%): 112.85237520414684
Free cash flow (dilution-adjusted): -46590000
Buyback yield (%): 0
Retained earnings: -1380073000
Receivables turnover: 9.732550103662751
Capitalized R&D asset: 85766790
ROCI (R&D-adjusted, %): -30.280441025348704
FCF margin (%): -330.82439821060854
Revenue growth (%): 128.21260735699238
Rule of 40 score: -202.61179085361616
Financial ratios for ADBE — annual report dated 2021-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 669.85
Shares outstanding: 397500000
Market cap (USD): 266265375000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ADBE — annual report dated 2022-11-30
Total revenue: 17606000000
Gross profit: 15441000000
Operating income: 6098000000
Net income: 4756000000
Capital expenditures: 442000000
Operating cash flow: 7838000000
Depreciation & amortization: 856000000
Net tangible assets: -185000000
Owner earnings: 5170000000
Return on net tangible assets (%): -2794.5945945945946
Capex to operating income (%): 7.248278123975075
Buffett classification: The Great
Stock price: 344.93
P/E ratio: 28.828779436501264
Shares outstanding: 397500000
Book value: 14051000000
P/B ratio: 9.7580012098783
Market cap (USD): 137109675000
Debt to equity: 0.32972742153583373
Current ratio: 1.106791338582677
Quick ratio: 1.106791338582677
Effective tax rate (%): 20.838881491344875
Interest coverage ratio: 54.44642857142857
COGS to revenue (%): 12.29694422356015
R&D to revenue (%): 16.965807111212087
SG&A to revenue (%): 35.141429058275584
Free cash flow (dilution-adjusted): 5956000000
Buyback yield (%): 4.77719752453647
Retained earnings: 28319000000
Receivables turnover: 8.52590799031477
Capitalized R&D asset: 2987000000
ROCI (R&D-adjusted, %): 36.72962828429592
FCF margin (%): 33.82937634897194
Rule of 40 score: 33.82937634897194
Financial ratios for ADBE — annual report dated 2023-11-30
Total revenue: 19409000000
Gross profit: 17055000000
Operating income: 6650000000
Net income: 5428000000
Capital expenditures: 360000000
Operating cash flow: 7302000000
Depreciation & amortization: 872000000
Net tangible assets: 2625000000
Owner earnings: 5940000000
Return on net tangible assets (%): 226.28571428571428
Capex to operating income (%): 5.413533834586466
Buffett classification: The Great
Stock price: 611.01
P/E ratio: 44.745113301400146
Shares outstanding: 397500000
Book value: 16518000000
P/B ratio: 14.703745913548856
Market cap (USD): 242876475000
Debt to equity: 0.24700326916091536
Current ratio: 1.3433523209307963
Quick ratio: 1.3433523209307963
Effective tax rate (%): 20.16473010736873
Interest coverage ratio: 58.849557522123895
COGS to revenue (%): 12.128394044000206
R&D to revenue (%): 17.893760626513473
SG&A to revenue (%): 34.849811942913085
Free cash flow (dilution-adjusted): 5224000000
Buyback yield (%): 1.8116204955626107
Retained earnings: 33346000000
Receivables turnover: 8.72706834532374
Capitalized R&D asset: 5474290000
ROCI (R&D-adjusted, %): 29.51478065996131
Rosenberg metric: 0.5403414797455641
FCF margin (%): 26.91534854964192
Revenue growth (%): 10.240826990798592
Rule of 40 score: 37.156175540440515
Financial ratios for ADBE — quarterly report dated 2024-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 574.41
Shares outstanding: 397500000
Market cap (USD): 228327975000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ADBE — annual report dated 2024-11-30
Total revenue: 21505000000
Gross profit: 19147000000
Operating income: 7741000000
Net income: 5560000000
Capital expenditures: 183000000
Operating cash flow: 8056000000
Depreciation & amortization: 857000000
Net tangible assets: 535000000
Owner earnings: 6234000000
Return on net tangible assets (%): 1165.233644859813
Capex to operating income (%): 2.364035654308229
Buffett classification: The Great
Stock price: 515.93
P/E ratio: 36.88528327338129
Shares outstanding: 397500000
Book value: 14105000000
P/B ratio: 14.539679191775965
Market cap (USD): 205082174999.99997
Debt to equity: 0.4293512938674229
Current ratio: 1.067579127459367
Quick ratio: 1.067579127459367
Effective tax rate (%): 19.780695426345403
Interest coverage ratio: 45.80473372781065
COGS to revenue (%): 10.964891885607999
R&D to revenue (%): 18.3399209486166
SG&A to revenue (%): 33.91304347826087
Free cash flow (dilution-adjusted): 6040000000
Buyback yield (%): 4.632289471281452
Retained earnings: 38470000000
Receivables turnover: 10.378861003861005
Capitalized R&D asset: 7256620000
ROCI (R&D-adjusted, %): 30.47213451795286
Rosenberg metric: 0.6023610711200691
FCF margin (%): 28.086491513601487
Revenue growth (%): 10.799113813179453
Rule of 40 score: 38.88560532678094
Financial ratios for ADBE — quarterly report dated 2024-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 515.93
Shares outstanding: 397500000
Market cap (USD): 205082174999.99997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ADBE — quarterly report dated 2025-02-28
Total revenue: 5714000000
Gross profit: 5092000000
Operating income: 2163000000
Net income: 1811000000
Capital expenditures: 26000000
Operating cash flow: 2482000000
Depreciation & amortization: 217000000
Net tangible assets: -388000000
Owner earnings: 2002000000
Return on net tangible assets (%): -515.979381443299
Capex to operating income (%): 1.2020342117429497
Buffett classification: The Great
Stock price: 438.56
P/E ratio: 24.06510215350635
Shares outstanding: 397500000
Book value: 13095000000
P/B ratio: 13.312531500572737
Market cap (USD): 174327600000
Debt to equity: 0.5011836578846888
Current ratio: 1.1846556804539998
Quick ratio: 1.1846556804539998
Effective tax rate (%): 17.00274977085243
Interest coverage ratio: 34.88709677419355
COGS to revenue (%): 10.885544277213862
R&D to revenue (%): 17.955897794889744
SG&A to revenue (%): 32.58662933146657
Free cash flow (dilution-adjusted): 1981000000
Buyback yield (%): 1.864306053659891
Retained earnings: 40186000000
Receivables turnover: 2.8960973137354284
Capitalized R&D asset: 1026000000
ROCI (R&D-adjusted, %): 13.048858740489505
FCF margin (%): 34.66923346167308
Rule of 40 score: 34.66923346167308
Financial ratios for ADBE — quarterly report dated 2025-05-31
Total revenue: 5873000000
Gross profit: 5235000000
Operating income: 2109000000
Net income: 1691000000
Capital expenditures: 47000000
Operating cash flow: 2191000000
Depreciation & amortization: 209000000
Net tangible assets: -2013000000
Owner earnings: 1853000000
Return on net tangible assets (%): -92.05166418281172
Capex to operating income (%): 2.2285443338074917
Buffett classification: The Great
Stock price: 415.09
P/E ratio: 47.11544117647058
Shares outstanding: 397500000
Book value: 11448000000
P/B ratio: 14.41284722222222
Market cap (USD): 164998275000
Debt to equity: 0.5732879105520615
Current ratio: 0.9932514658701184
Quick ratio: 0.9932514658701184
Effective tax rate (%): 19.51451689671585
Interest coverage ratio: 31.014705882352942
COGS to revenue (%): 10.86327260343947
R&D to revenue (%): 18.423293035927124
SG&A to revenue (%): 34.10522731142517
Free cash flow (dilution-adjusted): 1663000000
Buyback yield (%): 2.1212342977525065
Retained earnings: 41744000000
Receivables turnover: 3.385014409221902
Capitalized R&D asset: 1769420000
ROCI (R&D-adjusted, %): 11.941657524460004
Rosenberg metric: 0.13937621832358674
FCF margin (%): 28.316022475736418
Revenue growth (%): 2.7826391319565977
Rule of 40 score: 31.098661607693014
Financial ratios for ADBE — quarterly report dated 2025-08-31
Total revenue: 5988000000
Gross profit: 5346000000
Operating income: 2173000000
Net income: 1772000000
Capital expenditures: 72000000
Operating cash flow: 2198000000
Depreciation & amortization: 208000000
Net tangible assets: -1647000000
Owner earnings: 1908000000
Return on net tangible assets (%): -115.84699453551912
Capex to operating income (%): 3.313391624482283
Buffett classification: The Great
Stock price: 356.7
P/E ratio: 26.88438566552901
Shares outstanding: 397500000
Book value: 11770000000
P/B ratio: 12.046580288870008
Market cap (USD): 141788250000
Debt to equity: 0.5638062871707732
Current ratio: 1.018724970234874
Quick ratio: 1.018724970234874
Effective tax rate (%): 18.975765889346135
Interest coverage ratio: 32.43283582089552
COGS to revenue (%): 10.721442885771543
R&D to revenue (%): 18.169672678690716
SG&A to revenue (%): 34.18503674014696
Free cash flow (dilution-adjusted): 1629000000
Buyback yield (%): 1.4507549109323234
Retained earnings: 43516000000
Receivables turnover: 2.860965121834687
Capitalized R&D asset: 2151520000
ROCI (R&D-adjusted, %): 10.133914752653709
Rosenberg metric: 0.10258780036968576
FCF margin (%): 27.204408817635272
Revenue growth (%): 1.9581134003064875
Rule of 40 score: 29.16252221794176
Financial ratios for ADBE — quarterly report dated 2025-11-30
Total revenue: 6194000000
Gross profit: 5545000000
Operating income: 2261000000
Net income: 1856000000
Capital expenditures: 34000000
Operating cash flow: 3160000000
Depreciation & amortization: 184000000
Net tangible assets: -1729000000
Owner earnings: 2006000000
Return on net tangible assets (%): -116.02082128397917
Capex to operating income (%): 1.5037593984962405
Buffett classification: The Great
Stock price: 320.13
P/E ratio: 17.847359747545582
Shares outstanding: 397500000
Book value: 11623000000
P/B ratio: 10.948264217499785
Market cap (USD): 127251675000
Debt to equity: 0.5719693710745934
Current ratio: 0.9963725490196078
Quick ratio: 0.9963725490196078
Effective tax rate (%): 18.021201413427562
Interest coverage ratio: 34.25757575757576
COGS to revenue (%): 10.47788182111721
R&D to revenue (%): 17.72683241846949
SG&A to revenue (%): 34.694865999354214
Free cash flow (dilution-adjusted): 2637000000
Buyback yield (%): 1.9441787308497118
Retained earnings: 45354000000
Receivables turnover: 2.6424914675767917
Capitalized R&D asset: 2184020000
ROCI (R&D-adjusted, %): 10.566408535311732
Rosenberg metric: 0.18290441176470587
FCF margin (%): 42.57345818534065
Revenue growth (%): 3.440213760855043
Rule of 40 score: 46.01367194619569
Financial ratios for ADBE — annual report dated 2025-11-30
Total revenue: 23769000000
Gross profit: 21218000000
Operating income: 8706000000
Net income: 7130000000
Capital expenditures: 179000000
Operating cash flow: 10031000000
Depreciation & amortization: 818000000
Net tangible assets: -1729000000
Owner earnings: 7769000000
Return on net tangible assets (%): -449.33487565066514
Capex to operating income (%): 2.0560532965770735
Buffett classification: The Great
Stock price: 320.13
P/E ratio: 17.847359747545582
Shares outstanding: 397500000
Book value: 11623000000
P/B ratio: 10.948264217499785
Market cap (USD): 127251675000
Debt to equity: 0.5719693710745934
Current ratio: 0.9963725490196078
Quick ratio: 0.9963725490196078
Effective tax rate (%): 18.365010304556904
Interest coverage ratio: 33.10266159695818
COGS to revenue (%): 10.732466658252346
R&D to revenue (%): 18.06554756195044
SG&A to revenue (%): 33.913921494383445
Free cash flow (dilution-adjusted): 7910000000
Buyback yield (%): 8.865109241194665
Retained earnings: 45354000000
Receivables turnover: 10.140358361774744
Capitalized R&D asset: 8082570000
ROCI (R&D-adjusted, %): 33.22428210579783
Rosenberg metric: 0.5251014198782962
FCF margin (%): 33.27864024569818
Revenue growth (%): 10.527784236224134
Rule of 40 score: 43.80642448192231
Financial ratios for AGY.L — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.0034722222222222225
Shares outstanding: 6332529550
Market cap (USD): 21987949.82638889
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AGY.L — annual report dated 2022-06-30
Total revenue: 88741463.41463415
Gross profit: 60373170.73170732
Operating income: -14932926.829268293
Net income: -16800000
Capital expenditures: 3726829.268292683
Operating cash flow: -17074390.24390244
Depreciation & amortization: 5080487.8048780495
Net tangible assets: 39914634.146341465
Owner earnings: -15446341.463414636
Return on net tangible assets (%): -38.69844179651696
Buffett classification: The Gruesome
Stock price: 0.0025609756097560977
Shares outstanding: 6332529550
Book value: 46054878.048780486
P/B ratio: 0.3521332465245598
Market cap (USD): 16217453.725609757
Debt to equity: 0.2788031245862571
Current ratio: 2.3482523680274747
Quick ratio: 1.7162244502298787
Interest coverage ratio: -18.303437967115098
COGS to revenue (%): 31.967348284960423
R&D to revenue (%): 21.519074318381705
SG&A to revenue (%): 64.3579595426561
Free cash flow (dilution-adjusted): -21373170.731707316
Buyback yield (%): 0
Retained earnings: -144563414.63414636
Inventory turnover: 2.038737949167397
Receivables turnover: 27.011135857461024
Capitalized R&D asset: 19096341.463414636
ROCI (R&D-adjusted, %): -2.559269023254056
FCF margin (%): -24.084762532981525
Rule of 40 score: -24.084762532981525
Financial ratios for AGY.L — annual report dated 2023-06-30
Total revenue: 75426582.278481
Gross profit: 42082278.48101266
Operating income: -44182278.48101266
Net income: -54520253.16455696
Capital expenditures: 5910126.582278481
Operating cash flow: -36558227.848101266
Depreciation & amortization: 5346835.443037975
Net tangible assets: -1300000
Owner earnings: -55083544.30379747
Buffett classification: The Gruesome
Stock price: 0.00012658227848101267
Shares outstanding: 6332529550
Book value: 5201265.822784811
P/B ratio: 0.15411364200535407
Market cap (USD): 801586.0189873418
Debt to equity: 8.75857872961791
Current ratio: 1.8058712631295446
Quick ratio: 1.181416644223
Interest coverage ratio: -14.299057763211799
COGS to revenue (%): 44.2076291808616
R&D to revenue (%): 33.76743249366473
SG&A to revenue (%): 82.03802842901975
Free cash flow (dilution-adjusted): -42612658.227848105
Buyback yield (%): 0
Retained earnings: -202312658.22784808
Inventory turnover: 2.272233244199086
Receivables turnover: 10.217249657064471
Capitalized R&D asset: 38264169.033652365
ROCI (R&D-adjusted, %): -33.11084232267111
Rosenberg metric: -0.9578218050686265
FCF margin (%): -56.49554433013913
Revenue growth (%): -15.00412617035727
Rule of 40 score: -71.4996705004964
Financial ratios for AGY.L — annual report dated 2024-06-30
Total revenue: 69872151.89873417
Gross profit: 37641772.151898734
Operating income: -43060759.49367088
Net income: -48887341.772151895
Capital expenditures: 4305063.29113924
Operating cash flow: -40681012.658227846
Depreciation & amortization: 5467088.607594936
Net tangible assets: 3378481.0126582277
Owner earnings: -47725316.455696195
Return on net tangible assets (%): -1412.626451854627
Buffett classification: The Gruesome
Stock price: 0.0006329113924050633
Shares outstanding: 6332529550
Book value: 9311392.405063286
P/B ratio: 0.4304329492930943
Market cap (USD): 4007930.094936709
Debt to equity: 4.212615551930399
Current ratio: 1.7808627200680816
Quick ratio: 1.1030264347641083
Interest coverage ratio: -8.282931580228876
COGS to revenue (%): 46.12764723998624
R&D to revenue (%): 41.4862588090364
SG&A to revenue (%): 67.57912281019584
Free cash flow (dilution-adjusted): -45946835.44303797
Buyback yield (%): 0
Retained earnings: -247186075.94936708
Inventory turnover: 1.9979598242310106
Receivables turnover: 19.286862334032143
Capitalized R&D asset: 52353780.02469899
ROCI (R&D-adjusted, %): -34.26915679781351
Rosenberg metric: -0.1743452114706028
FCF margin (%): -65.75843765285605
Revenue growth (%): -7.364022353869139
Rule of 40 score: -73.12246000672519
Financial ratios for AGY.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -14580000
Buffett classification: The Gruesome
Stock price: 0.0008750000000000001
Shares outstanding: 6332529550
Market cap (USD): 5540963.356250001
Current ratio: 1.5953461975028378
Quick ratio: 1.1460839954597049
Buyback yield (%): 0
Retained earnings: -262768750
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AGY.L — annual report dated 2025-06-30
Total revenue: 75402739.7260274
Gross profit: 40139726.02739726
Operating income: -38578082.19178082
Net income: -54975342.46575343
Capital expenditures: 4471232.876712329
Operating cash flow: -38505479.4520548
Depreciation & amortization: 5715068.493150685
Net tangible assets: -44450684.93150685
Owner earnings: -53731506.84931507
Buffett classification: The Gruesome
Stock price: 0.0010958904109589042
Shares outstanding: 6332529550
Book value: -38620547.94520548
Market cap (USD): 6939758.410958905
Debt to equity: -2.131344660021991
Current ratio: 1.2752647837599294
Quick ratio: 0.7635333921741689
Interest coverage ratio: -4.207679665321978
COGS to revenue (%): 46.76622338492842
R&D to revenue (%): 27.93583315166049
SG&A to revenue (%): 69.55889833587675
Free cash flow (dilution-adjusted): -44386301.36986302
Buyback yield (%): 0
Retained earnings: -322227397.260274
Inventory turnover: 1.8499461013295004
Receivables turnover: 19.34762741652021
Capitalized R&D asset: 48890877.23252991
ROCI (R&D-adjusted, %): -40.980157114370705
Rosenberg metric: 0.08617395465693604
FCF margin (%): -58.86563476491534
Revenue growth (%): 7.915296261819334
Rule of 40 score: -50.950338503096006
Financial ratios for AGY.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -44450684.93150685
Buffett classification: The Gruesome
Stock price: 0.0010958904109589042
Shares outstanding: 6332529550
Book value: -38620547.94520548
Market cap (USD): 6939758.410958905
Debt to equity: -2.131344660021991
Current ratio: 1.2752647837599294
Quick ratio: 0.7635333921741689
Buyback yield (%): 0
Retained earnings: -322227397.260274
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALOKINDS.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.33430040880917844
Shares outstanding: 4965240401
Market cap (USD): 1659881895.890149
Buyback yield (%): 0
Retained earnings: -2862398786.7598577
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALOKINDS.NS — annual report dated 2023-03-31
Total revenue: 840544457.9780756
Gross profit: 207259439.70767358
Operating income: -53085261.87576127
Net income: -107242387.33252132
Capital expenditures: 1911084.0438489649
Operating cash flow: 99058465.2862363
Depreciation & amortization: 44447015.83434836
Net tangible assets: -2302196102.314251
Owner earnings: -64706455.54202192
Buffett classification: The Gruesome
Stock price: 0.1412911084043849
Shares outstanding: 4965240401
Book value: -2302123020.7064557
Market cap (USD): 701544319.7515227
Debt to equity: -1.2657071823233652
Current ratio: 0.4096099675709485
Quick ratio: 0.17414695277958445
Interest coverage ratio: -0.9121980827996149
COGS to revenue (%): 75.34223945676413
SG&A to revenue (%): 2.3789754045504408
Free cash flow (dilution-adjusted): 93672350.79171742
Buyback yield (%): 0
Retained earnings: -2751038976.857491
Inventory turnover: 5.003965236807407
Receivables turnover: 20.017607472297968
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.297008266631678
FCF margin (%): 11.144247029722338
Rule of 40 score: 11.144247029722338
Financial ratios for ALOKINDS.NS — annual report dated 2024-03-31
Total revenue: 650136707.0392133
Gross profit: 187540472.47871447
Operating income: -32349202.542271256
Net income: -101549346.44441779
Capital expenditures: 3482431.946276532
Operating cash flow: -139192948.79481953
Depreciation & amortization: 38927929.00827438
Net tangible assets: -2372235280.0095935
Owner earnings: -66103849.382419944
Buffett classification: The Gruesome
Stock price: 0.31010076775431866
Shares outstanding: 4965240401
Book value: -2371491785.5858016
Market cap (USD): 1539724860.4348612
Debt to equity: -1.136404618355602
Current ratio: 0.6551826247811099
Quick ratio: 0.3109647984382483
Interest coverage ratio: -0.5402872078351258
COGS to revenue (%): 71.15368653266906
SG&A to revenue (%): 2.648164987853893
Free cash flow (dilution-adjusted): -143528000.95934764
Buyback yield (%): 0
Retained earnings: -2810031178.798417
Inventory turnover: 4.096976326773367
Receivables turnover: 11.66589202332537
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.774664771462333
FCF margin (%): -22.076587801508442
Revenue growth (%): -22.652906593053622
Rule of 40 score: -44.72949439456207
Financial ratios for ALOKINDS.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: -2419204491.161013
Buffett classification: The Gruesome
Stock price: 0.3168896321070234
Shares outstanding: 4965240401
Book value: -2418517677.9742
Market cap (USD): 1573433203.9958196
Debt to equity: -1.2805633986456821
Current ratio: 0.5766199333756225
Quick ratio: 0.2884562060569688
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALOKINDS.NS — quarterly report dated 2024-12-31
Total revenue: 100694719.66429654
Gross profit: 49491782.25900454
Operating income: -13547033.453782491
Net income: -31820725.02622683
Capital expenditures: 0
Depreciation & amortization: 8690989.625830516
Owner earnings: -23129735.400396314
Buffett classification: The Gruesome
Stock price: 0.24501690173679913
Shares outstanding: 4965240401
Market cap (USD): 1216567819.4314022
Interest coverage ratio: -0.7335268871497097
COGS to revenue (%): 50.84967471581044
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALOKINDS.NS — quarterly report dated 2025-03-31
Total revenue: 111405190.55412671
Gross profit: 54570960.95393968
Operating income: -11415711.94762684
Net income: -8705868.59948562
Capital expenditures: 0
Depreciation & amortization: 8724573.299041383
Net tangible assets: -2412360299.2751927
Owner earnings: 18704.699555762112
Buffett classification: The Gruesome
Stock price: 0.1756330960438791
Shares outstanding: 4965240401
Book value: -2411751227.4959083
Market cap (USD): 872060544.2297819
Debt to equity: -1.086771671711071
Current ratio: 0.926289850418113
Quick ratio: 0.39124742153435693
Interest coverage ratio: -0.627046811789636
COGS to revenue (%): 51.01578240429819
Buyback yield (%): 0
Retained earnings: -2834846855.272387
Inventory turnover: 0.5611718398300878
Receivables turnover: 2.168183472879505
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.9107009034005191
Revenue growth (%): 10.63657650126792
Rule of 40 score: 10.63657650126792
Financial ratios for ALOKINDS.NS — annual report dated 2025-03-31
Total revenue: 424079962.59060085
Gross profit: 177265606.73369184
Operating income: -42190787.935468785
Net income: -95444236.61444937
Capital expenditures: 6181903.203179798
Operating cash flow: 13469721.767594106
Depreciation & amortization: 34849193.35983165
Net tangible assets: -2412360299.2751927
Owner earnings: -66776946.45779751
Buffett classification: The Gruesome
Stock price: 0.1756330960438791
Shares outstanding: 4965240401
Book value: -2411751227.4959083
Market cap (USD): 872060544.2297819
Debt to equity: -1.086771671711071
Current ratio: 0.926289850418113
Quick ratio: 0.39124742153435693
Interest coverage ratio: -1.17358220603538
COGS to revenue (%): 58.199956996124136
SG&A to revenue (%): 2.7056605229932904
Free cash flow (dilution-adjusted): 4191021.7442132332
Buyback yield (%): 0
Retained earnings: -2834846855.272387
Inventory turnover: 2.4370043747763557
Receivables turnover: 8.253503822351655
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.061668776623117
FCF margin (%): 0.9882621472166018
Revenue growth (%): -34.77064777315792
Rule of 40 score: -33.782385625941316
Financial ratios for ALOKINDS.NS — quarterly report dated 2025-06-30
Total revenue: 109114205.47624621
Gross profit: 57213901.240346365
Operating income: -5623683.59466417
Net income: -20074888.836882755
Capital expenditures: 0
Depreciation & amortization: 7981511.818394572
Owner earnings: -12093377.018488184
Buffett classification: The Gruesome
Stock price: 0.23894219517903117
Shares outstanding: 4965240401
Market cap (USD): 1186405441.006553
Interest coverage ratio: -0.30833386796689544
COGS to revenue (%): 47.56512134178383
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -2.0564437496001737
Rule of 40 score: -2.0564437496001737
Financial ratios for ALOKINDS.NS — quarterly report dated 2025-12-31
Total revenue: 95604322.15662248
Gross profit: 49412944.19070959
Operating income: -7245182.132115406
Net income: -24243065.612119865
Capital expenditures: 0
Depreciation & amortization: 7279714.826779548
Owner earnings: -16963350.785340317
Buffett classification: The Gruesome
Stock price: 0.17856745015038433
Shares outstanding: 4965240401
Market cap (USD): 886630317.7902418
Interest coverage ratio: -0.4252648097293056
COGS to revenue (%): 48.31515659955258
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -12.381415655878811
Rule of 40 score: -12.381415655878811
Financial ratios for ALREA.PA — annual report dated 2021-12-31
Total revenue: 324656818.1818182
Gross profit: 95726136.36363636
Operating income: 23118181.818181816
Net income: 12007954.545454545
Capital expenditures: 10723863.636363637
Operating cash flow: -22998863.636363637
Depreciation & amortization: 16944318.181818184
Net tangible assets: 75726136.36363636
Owner earnings: 18228409.09090909
Return on net tangible assets (%): 24.07148966821231
Capex to operating income (%): 46.387141171844284
Buffett classification: The Good
Stock price: 31.454545454545453
P/E ratio: 12.434195484054133
Shares outstanding: 4746826
Book value: 125494318.18181825
P/B ratio: 1.189769037714492
Market cap (USD): 149309254.1818182
Debt to equity: 3.1004663376646877
Current ratio: 1.695145860325805
Quick ratio: 0.8625939493364901
Effective tax rate (%): 10.410308579179382
COGS to revenue (%): 70.51466933615215
Free cash flow (dilution-adjusted): -34447727.27272727
Buyback yield (%): 0
Retained earnings: 9136363.636363637
Inventory turnover: 0.7518361223484452
Receivables turnover: 2.8973693284384314
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.185298465616556
FCF margin (%): -10.61050479877353
Rule of 40 score: -10.61050479877353
Financial ratios for ALREA.PA — annual report dated 2022-12-31
Total revenue: 371812765.9574468
Gross profit: 91106382.9787234
Operating income: 28221276.59574468
Net income: 13308510.638297873
Capital expenditures: 8955319.148936171
Operating cash flow: -57128723.40425532
Depreciation & amortization: 20013829.78723404
Net tangible assets: 107413829.78723405
Owner earnings: 24367021.276595745
Return on net tangible assets (%): 22.685180599986133
Capex to operating income (%): 31.732509047044637
Buffett classification: The Good
Stock price: 27.75531914893617
P/E ratio: 9.899655502797762
Shares outstanding: 4746826
Book value: 153722340.42553186
P/B ratio: 0.8570626117827808
Market cap (USD): 131749670.57446809
Debt to equity: 2.8323033377393627
Current ratio: 1.3736485920010293
Quick ratio: 0.7266241755070765
Effective tax rate (%): 20.8077483066405
COGS to revenue (%): 75.49670390038455
Free cash flow (dilution-adjusted): -67517021.27659574
Buyback yield (%): 0
Retained earnings: 11430851.063829787
Inventory turnover: 0.7951231418730582
Receivables turnover: 1.6751533742331286
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.396512396136245
FCF margin (%): -18.158876579381065
Revenue growth (%): 14.524859831904035
Rule of 40 score: -3.6340167474770304
Financial ratios for ALREA.PA — annual report dated 2023-12-31
Total revenue: 446686666.6666666
Gross profit: 116112222.22222222
Operating income: -20551111.111111112
Net income: 3042222.222222222
Capital expenditures: 29426666.666666664
Operating cash flow: -71480000
Depreciation & amortization: 14323333.333333332
Net tangible assets: 124006666.66666666
Owner earnings: -12061111.111111112
Return on net tangible assets (%): -9.726179596079065
Buffett classification: The Gruesome
Stock price: 19.61111111111111
P/E ratio: 30.59951749452155
Shares outstanding: 4746826
Book value: 200850000.00000012
P/B ratio: 0.46348285840732417
Market cap (USD): 93090532.1111111
Debt to equity: 2.071097834204629
Current ratio: 1.118480022301257
Quick ratio: 0.49941796170188
COGS to revenue (%): 74.00589028351965
Free cash flow (dilution-adjusted): -105788888.88888888
Buyback yield (%): 0
Retained earnings: 3042222.222222222
Inventory turnover: 0.7361148224023435
Receivables turnover: 3.7012438200281723
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.844256219667742
FCF margin (%): -23.683019168295946
Revenue growth (%): 20.137528230482804
Rule of 40 score: -3.545490937813142
Financial ratios for BBSN.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.003783783783783784
Shares outstanding: 116319751
Market cap (USD): 440128.7875675676
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBSN.L — annual report dated 2022-12-31
Total revenue: 38134939.759036146
Gross profit: 20419277.108433735
Operating income: 1761445.7831325303
Net income: 2506024.0963855423
Capital expenditures: 97590.36144578314
Operating cash flow: 2062650.6024096387
Depreciation & amortization: 719277.108433735
Net tangible assets: 4520481.927710843
Owner earnings: 3127710.843373494
Return on net tangible assets (%): 69.18976545842219
Capex to operating income (%): 5.540355677154583
Buffett classification: The Great
Stock price: 0.005301204819277109
P/E ratio: 0.24606101173076925
Shares outstanding: 116319751
Book value: 12074698.795180725
P/B ratio: 0.05106834009179804
Market cap (USD): 616634.8245783134
Debt to equity: 0.06994611853921373
Current ratio: 1.4177537708927845
Quick ratio: 1.4177537708927845
Effective tax rate (%): -42.85714285714286
Interest coverage ratio: 17
COGS to revenue (%): 46.45520030329837
SG&A to revenue (%): 48.925818273726776
Free cash flow (dilution-adjusted): 1498795.1807228916
Buyback yield (%): 0
Retained earnings: -145784337.3493976
Receivables turnover: 6.297652208515718
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.55083881731393
FCF margin (%): 3.9302413749526095
Rule of 40 score: 3.9302413749526095
Financial ratios for BBSN.L — annual report dated 2023-12-31
Total revenue: 45194936.708860755
Gross profit: 26458227.848101266
Operating income: 1335443.0379746836
Net income: 4289873.417721519
Capital expenditures: 197468.35443037972
Operating cash flow: 2307594.9367088606
Depreciation & amortization: 1369620.2531645568
Net tangible assets: 7510126.582278481
Owner earnings: 5462025.316455697
Return on net tangible assets (%): 72.72880498904433
Capex to operating income (%): 14.786729857819903
Buffett classification: The Great
Stock price: 0.005316455696202531
P/E ratio: 0.14415548958394805
Shares outstanding: 116319751
Book value: 23536708.86075949
P/B ratio: 0.02627422578251049
Market cap (USD): 618408.8027848101
Debt to equity: 0.0996020221576853
Current ratio: 1.4801805769654262
Quick ratio: 1.4801805769654262
Effective tax rate (%): -205.31531531531533
Interest coverage ratio: 7.377622377622378
COGS to revenue (%): 41.45753977145418
SG&A to revenue (%): 55.58760923145866
Free cash flow (dilution-adjusted): 1559493.6708860756
Buyback yield (%): 0
Retained earnings: -148326582.278481
Receivables turnover: 8.525310410697228
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.926453420499651
FCF margin (%): 3.450593771006049
Revenue growth (%): 18.513198118142377
Rule of 40 score: 21.963791889148425
Financial ratios for BBSN.L — annual report dated 2024-12-31
Total revenue: 41035000
Gross profit: 26676250
Operating income: 2368750
Net income: 2826250
Capital expenditures: 208750
Operating cash flow: 2028750
Depreciation & amortization: 1288750
Net tangible assets: 11271250
Owner earnings: 3906250
Return on net tangible assets (%): 34.65675945436398
Capex to operating income (%): 8.812664907651715
Buffett classification: The Great
Stock price: 0.005124999999999999
P/E ratio: 0.21092922560813798
Shares outstanding: 116319751
Book value: 26613750
P/B ratio: 0.022399651453665865
Market cap (USD): 596138.7238749999
Debt to equity: 0.08675027006716453
Current ratio: 1.78010878010878
Quick ratio: 1.78010878010878
Effective tax rate (%): -15.829918032786885
Interest coverage ratio: 9.717948717948717
COGS to revenue (%): 34.99147069574754
SG&A to revenue (%): 59.23601803338613
Free cash flow (dilution-adjusted): 1341250
Buyback yield (%): 0
Retained earnings: -143166250
Receivables turnover: 6.656123276561233
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.999155761924863
FCF margin (%): 3.2685512367491167
Revenue growth (%): -9.204430876092305
Rule of 40 score: -5.935879639343188
Financial ratios for BBSN.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 11271250
Buffett classification: The Gruesome
Stock price: 0.005124999999999999
Shares outstanding: 116319751
Book value: 26613750
P/B ratio: 0.022399651453665865
Market cap (USD): 596138.7238749999
Debt to equity: 0.08675027006716453
Current ratio: 1.78010878010878
Quick ratio: 1.78010878010878
Buyback yield (%): 0
Retained earnings: -143166250
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBSN.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 2665753.4246575343
Buffett classification: The Gruesome
Stock price: 0.008493150684931507
Shares outstanding: 116319751
Book value: 32497260.273972604
P/B ratio: 0.030400137259199933
Market cap (USD): 987921.1728767124
Debt to equity: 0.07966951903216288
Current ratio: 1.036691393475313
Quick ratio: 1.036691393475313
Buyback yield (%): 0
Retained earnings: -154641095.89041096
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIPC.TO — annual report dated 2021-12-31
Capital expenditures: 417000000
Buffett classification: The Gruesome
Stock price: 38.09448818897638
Shares outstanding: 122990668
Market cap (USD): 4685266549.480315
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIPC.TO — annual report dated 2022-12-31
Total revenue: 1886000000
Gross profit: 1344000000
Operating income: 1275000000
Net income: 1619000000
Capital expenditures: 4000000
Operating cash flow: 893000000
Depreciation & amortization: 211000000
Net tangible assets: -4484000000
Owner earnings: 1826000000
Return on net tangible assets (%): -40.72256913470116
Capex to operating income (%): 0.3137254901960784
Buffett classification: The Great
Stock price: 33.56617647058823
P/E ratio: 2.549923697543872
Shares outstanding: 122990668
Book value: -361000000
Market cap (USD): 4128326466.323529
Debt to equity: -12.750692520775623
Current ratio: 0.33822577163824735
Quick ratio: 0.33822577163824735
Effective tax rate (%): 13.92876129718235
Interest coverage ratio: 2.34375
COGS to revenue (%): 28.738069989395548
SG&A to revenue (%): 3.6585365853658534
Free cash flow (dilution-adjusted): 893000000
Buyback yield (%): 0
Retained earnings: 901000000
Receivables turnover: 1.8728897715988084
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.993688007213706
FCF margin (%): 47.348886532343585
Rule of 40 score: 47.348886532343585
Financial ratios for BIPC.TO — annual report dated 2023-12-31
Total revenue: 2503000000
Gross profit: 1725000000
Operating income: 1658000000
Net income: 606000000
Capital expenditures: 75000000
Operating cash flow: 1059000000
Depreciation & amortization: 365000000
Net tangible assets: -5824000000
Owner earnings: 896000000
Return on net tangible assets (%): -15.384615384615385
Capex to operating income (%): 4.523522316043426
Buffett classification: The Great
Stock price: 31.878787878787875
P/E ratio: 6.46995613241324
Shares outstanding: 122990668
Book value: 4068000000
P/B ratio: 0.963813524150055
Market cap (USD): 3920793416.242424
Debt to equity: 2.9631268436578173
Current ratio: 0.4409498348796981
Quick ratio: 0.4409498348796981
Effective tax rate (%): 37.782340862423
Interest coverage ratio: 2.3787661406025826
COGS to revenue (%): 31.082700759089093
SG&A to revenue (%): 2.6767878545745107
Free cash flow (dilution-adjusted): 1059000000
Buyback yield (%): 0
Retained earnings: 1115000000
Receivables turnover: 1.1502757352941178
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.447293447293447
FCF margin (%): 42.30922892528965
Revenue growth (%): 32.71474019088017
Rule of 40 score: 75.02396911616982
Financial ratios for BIPC.TO — quarterly report dated 2024-09-30
Capital expenditures: 354000000
Buffett classification: The Gruesome
Stock price: 40.525925925925925
Shares outstanding: 122990668
Market cap (USD): 4984310700.948148
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIPC.TO — annual report dated 2024-12-31
Total revenue: 3666000000
Gross profit: 2288000000
Operating income: 2213000000
Net income: 72000000
Capital expenditures: 315000000
Operating cash flow: 1743000000
Depreciation & amortization: 775000000
Net tangible assets: -5754000000
Owner earnings: 532000000
Return on net tangible assets (%): -9.245742092457421
Capex to operating income (%): 14.234071396294624
Buffett classification: The Great
Stock price: 37.91608391608392
P/E ratio: 64.76839567754469
Shares outstanding: 122990668
Book value: 2222000000
P/B ratio: 2.098705890541502
Market cap (USD): 4663324488.783217
Debt to equity: 5.526552655265527
Current ratio: 0.622907949790795
Quick ratio: 0.622907949790795
Effective tax rate (%): 83.52402745995423
Interest coverage ratio: 2.0779342723004697
COGS to revenue (%): 37.5886524822695
SG&A to revenue (%): 2.0458265139116203
Free cash flow (dilution-adjusted): 1743000000
Buyback yield (%): 0
Retained earnings: 509000000
Receivables turnover: 1.8023598820058997
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.884183449400842
FCF margin (%): 47.54500818330605
Revenue growth (%): 46.46424290850979
Rule of 40 score: 94.00925109181584
Financial ratios for BIPC.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 165000000
Buffett classification: The Gruesome
Stock price: 37.91608391608392
Shares outstanding: 122990668
Market cap (USD): 4663324488.783217
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIPC.TO — quarterly report dated 2025-03-31
Total revenue: 929000000
Gross profit: 574000000
Operating income: 555000000
Net income: 762000000
Capital expenditures: 74000000
Operating cash flow: 243000000
Depreciation & amortization: 195000000
Net tangible assets: -5530000000
Owner earnings: 883000000
Return on net tangible assets (%): -15.96745027124774
Capex to operating income (%): 13.333333333333334
Buffett classification: The Great
Stock price: 34.53146853146853
P/E ratio: 1.3933885766752931
Shares outstanding: 122990668
Book value: 2822000000
P/B ratio: 1.5049781650270355
Market cap (USD): 4247048381.706294
Debt to equity: 4.308291991495393
Current ratio: 0.48167451244115667
Quick ratio: 0.48167451244115667
Effective tax rate (%): 11.085180863477246
Interest coverage ratio: 2.032967032967033
COGS to revenue (%): 38.213132400430574
SG&A to revenue (%): 2.045209903121636
Free cash flow (dilution-adjusted): 108000000
Buyback yield (%): 0
Retained earnings: 898000000
Receivables turnover: 0.3626073380171741
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.3389483816628567
FCF margin (%): 11.6254036598493
Rule of 40 score: 11.6254036598493
Financial ratios for BIPC.TO — quarterly report dated 2025-06-30
Total revenue: 866000000
Gross profit: 563000000
Operating income: 543000000
Net income: -309000000
Capital expenditures: 168000000
Operating cash flow: 478000000
Depreciation & amortization: 153000000
Net tangible assets: -6057000000
Owner earnings: -324000000
Capex to operating income (%): 30.939226519337016
Buffett classification: The Good
Stock price: 39.73722627737226
P/E ratio: 10.788759391437456
Shares outstanding: 122990668
Book value: 2211000000
P/B ratio: 2.2104513814206994
Market cap (USD): 4887308004.321167
Debt to equity: 5.993215739484397
Current ratio: 0.49500888828114314
Quick ratio: 0.49500888828114314
Interest coverage ratio: 2.033707865168539
COGS to revenue (%): 34.98845265588915
SG&A to revenue (%): 2.3094688221709005
Free cash flow (dilution-adjusted): 269000000
Buyback yield (%): 0
Retained earnings: 421000000
Receivables turnover: 0.36961160904822876
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2716756040248236
FCF margin (%): 31.062355658198616
Revenue growth (%): -6.7814854682454255
Rule of 40 score: 24.28087018995319
Financial ratios for BIPC.TO — quarterly report dated 2025-09-30
Total revenue: 917000000
Gross profit: 581000000
Operating income: 561000000
Net income: 320000000
Capital expenditures: 45000000
Operating cash flow: 389000000
Depreciation & amortization: 167000000
Net tangible assets: -6105000000
Owner earnings: 442000000
Return on net tangible assets (%): -7.239967239967241
Capex to operating income (%): 8.02139037433155
Buffett classification: The Great
Stock price: 39.92805755395684
P/E ratio: 6.35288288551565
Shares outstanding: 122990668
Book value: 2198000000
P/B ratio: 2.234203125797815
Market cap (USD): 4910778470.503598
Debt to equity: 6.13557779799818
Current ratio: 0.4142078031044609
Quick ratio: 0.4142078031044609
Effective tax rate (%): 23.076923076923077
Interest coverage ratio: 1.7980769230769231
COGS to revenue (%): 36.6412213740458
SG&A to revenue (%): 2.1810250817884405
Free cash flow (dilution-adjusted): 389000000
Buyback yield (%): 0
Retained earnings: 503000000
Receivables turnover: 0.3633122028526149
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.3307605533456033
FCF margin (%): 42.420937840785164
Revenue growth (%): 5.8891454965357966
Rule of 40 score: 48.31008333732096
Financial ratios for BIPC.TO — quarterly report dated 2025-12-31
Total revenue: 956000000
Gross profit: 616000000
Operating income: 595000000
Net income: -73000000
Capital expenditures: 66000000
Operating cash flow: 498000000
Depreciation & amortization: 153000000
Net tangible assets: -6081000000
Owner earnings: 14000000
Capex to operating income (%): 11.092436974789916
Buffett classification: The Great
Stock price: 44.583941605839414
P/E ratio: 7.833441085964546
Shares outstanding: 122990668
Book value: 2005000000
P/B ratio: 2.734867212057447
Market cap (USD): 5483408760.175182
Debt to equity: 6.617955112219452
Current ratio: 0.3841940532081377
Quick ratio: 0.3841940532081377
Effective tax rate (%): 484.2105263157895
Interest coverage ratio: 1.9636963696369636
COGS to revenue (%): 35.56485355648535
SG&A to revenue (%): 2.1966527196652716
Free cash flow (dilution-adjusted): 498000000
Buyback yield (%): 0
Retained earnings: 268000000
Receivables turnover: 0.3890923890923891
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6375863544659777
FCF margin (%): 52.09205020920502
Revenue growth (%): 4.252998909487459
Rule of 40 score: 56.34504911869248